Immunocore reports Phase 1 data for melanoma drug brenetafusp

Immunocore reports Phase 1 data for melanoma drug brenetafusp

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.